Omnicell, Inc.
Omnicell, Inc. (OMCL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · OMCL · as of Jun 9, 2026
Key Statistics
Explore Omnicell, Inc. Data
omcl stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 19 · Buy rate: 47.4%
The OMCL analyst consensus is Hold, based on ratings from 19 Wall Street analysts over the past 3 months. The average 12-month price target is $57.20, representing +36.35% upside from the current price of $41.95.
Competitors & Peers
omcl competitorsOMCL
ASTH
GDRX
OMDA
PGNY
PHRStock Performance
Full HistoryAbout Omnicell, Inc.
Omnicell, Inc. founded in 1992 and headquartered in Mountain View, California (initially operating as Omnicell Technologies, Inc. until its name change in 2001), delivers advanced medication manageme…
what is omnicell, inc. · omcl stock overview · omnicell, inc. company profile · who is omnicell, inc. ceo · omcl NASDAQ · omnicell, inc. headquarters · omnicell, inc. business segments
About Stock Overview & Key Data
Omnicell, Inc. (OMCL) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Aug 9, 2001. As of the latest trading session, OMCL stock price is $41.95, with a market capitalization of $1.9B. The stock has returned +32.42% over the past 12 months and -7.40% year-to-date.
According to 19 Wall Street analysts, the consensus rating for Omnicell, Inc. stock is Hold, with an average 12-month price target of $57.20. In fiscal year 2025, Omnicell, Inc. reported revenue of $1.2B and net income of $2.1M. For detailed data — including Omnicell, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Omnicell, Inc. (OMCL) stock price is $41.95. The stock is traded on NASDAQ under the ticker symbol OMCL. The 52-week range is $26.85 – $55.00.